Jan Basile to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Jan Basile has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.067
-
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2001 Apr; 24(4):654-8.
Score: 0.042
-
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT. Clin Nephrol. 2013 Oct; 80(4):235-48.
Score: 0.025